Featured Cancer Videos |view more
Carl June, MD, reviews trial data and discusses his experience using immunotherapy to treat pancreatic cancer patients, specifically those with metastatic pancreatic ductal adenocarcinoma (PDA) at Penn’s Abramson Cancer Center.
Surgeons at Penn Medicine are using TumorGlow--an innovative technology based on fluorescent dyes--to identify cancer cells for precision tumor surgery.
Penn’s Brain Tumor Center sees the highest volume of brain tumor patients in Pennsylvania. Our clinical team frequently evaluates, diagnoses and treats a variety of cases, including atypical and rare cases, for both primary and metastatic tumors of the brain.
The Penn Pancreatic Cancer Research Center of the Abramson Cancer Center is at the vanguard of clinical investigation and current therapies for pancreatic cancer, predicted to be the second leading cause of cancer deaths in the United States.
Sunil Singhal, MD, a general thoracic surgeon and researcher at Penn Medicine, outlines his innovative approach to intraoperative, fluorescent-guided surgery (TumorGlow™) to address solid tumor recurrence.
Featured Articles |view more
Researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone.
Clinical Briefing - Endocrine and Oncologic Surgery, April 24, 2018
Penn Medicine News